bladder cancer in neurogenic patients a retrospective study of management and followup introduction the prevalence of bladder cancer bc in neurological patients seems to be similar to that of the general population however they are more aggressive with a higher rate of muscleinvasive forms and squamous cells carcinomas the aim of the current study was to report etiologies management and outcomes of bc in neurological populationmaterial and method were enrolled all neurological patients with a bc diagnosed between 2004 and 2017 the following data were retrospectively reported age gender duration of the disease mode of discovery histological type treatment and outcomesresults in total 27 patients were included 11 spinal cord injuries 7 parkinsons disease 5 multiple sclerosis 3 head trauma 3 brain strokes 2 cerebral palsies and 1 spina bifida the histological subtypes were as follows 22 transitional cells carcinomas 4 squamous cell carcinomas scc one mucinous adenocarcinoma one sarcomatoid and one neuroendocrine with 19 highgrade tumors and 15 muscleinvasive bladder cancer seven patients 26 were diagnosed before 15 years history of neurogenic bladder the mean followup was 14 months 1210 months eight deaths were observed with 5 related to bladder cancer in our study smoking habits voiding mode lithiasis or infection histories were not related with a more aggressive pattern such as sccconclusion the high rate of muscleinvasive bladder cancer and aggressive patterns justify neurourological followup even before 15 years of neurogenic bladderlevel of evidence 4